Authors
Wenjun Jiang, Yidan Zhu, Jingyi Kang, Ziyi Zhu, Kun Qian, Haiwei Ji, Qi Wang, Yuling Qin, Li Wu
Published in
Analytica chimica acta. Volume 1425. Pages 346312. Dec 01, 2026. Epub Sep 22, 2026.
Abstract
Mycotoxin contamination in agricultural commodities poses serious health risks, necessitating sensitive and user-friendly detection methods for food safety monitoring. Here, we present a multiplex CRISPR/Cas12a-assisted lateral flow assay (MC-LFA) for the parallel detection of Ochratoxin A (OTA) and Aflatoxin B1 (AFB1). The platform employs a duplex Switch design in which target binding releases an activator sequence (Probe 2), triggering Cas12a trans-cleavage of a half-blocking reporter (HBR). Cleavage generates dsDNA products labeled with Dig/FAM (for OTA) or TAMRA/FAM (for AFB1), which are captured at distinct test lines via specific antibody recognition. An integrated streptavidin (SA) capture line binds intact HBR through biotin-streptavidin interactions, effectively replacing conventional magnetic separation steps. The total assay time is approximately 65 min, including a 45-min target identification and a 15-min Cas12a reaction followed by a 5-min lateral flow readout. This approach achieves visual detection limits of 50 pg/mL for OTA and 250 pg/mL for AFB1. The assay exhibits excellent linear correlation over broad concentration ranges and demonstrates high accuracy in double-blind testing (97.22% for OTA and 94.44% for AFB1). Notably, the platform requires only aptamer replacement for different targets while maintaining the same Cas12a and crRNA sequences, substantially reducing experimental costs. Furthermore, by co-localizing detection probes in a single tube, an "OR" logic gate strategy enables parallel screening for both mycotoxins with a single test line. This cost-effective, sensitive, and operationally simple platform possesses strong potential for on-site food safety monitoring in resource-limited settings.
PMID:
42951549
Bibliographic data and abstract were imported from PubMed on 29 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0